Clinical Trial Update: Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received Atezolizumab & Bevacizumab [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating FOLFOX chemotherapy with atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma who previously received atezol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• FOLFOX regimen (folinic acid (leucovorin) + fluorouracil + oxaliplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma (HCC) | Phase 2 | Status: RECRUITING